MEMANTINE
DrugBank ID: db01043
DrugCentral: memantine
Synonymous :1-amino-3,5-dimethyladamantane | 1,3-dimethyl-5-adamantanamine | 3,5-dimethyl-1-adamantanamine | 3,5-dimethyl-1-aminoadamantane | 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine | memantina | memantine | memantinum
Drug Sentece Context
Table 1. Analysis of context sentence of memantine gene in 8 abstracts.
| pmid | sentence |
|---|---|
| 32388458 | They were receiving treatment with either amantadine (n=15) or memantine (n=7) in stable registered doses. |
| 32436995 | Memantine, a moderate affinity, uncompetitive N-Methyl-D-aspartic acid (NMDA) receptor antagonist which prevents excess calcium entry into cells is commonly utilized in treating patients with Alzheimer’s disease, and may inhibit the neurotoxicity induced by SARS-CoV-2 in the medullary brain stem to avoid development of ARDS. […] Memantine and related adamantine such as amantadine, which is utilized in Parkinson’s disease and influenza, may have some anti-viral potential as well. […] Memantine and similar adamantines may have potential as repurposed medicines for treating Covid19 with inhibition of neurotoxicity, ARDS and viral replication, since Memantine appears to be lysosomotropic. |
| 32662982 | Furthermore, some calcium channel blockers (CCBs), such as nimodipine, memantine, etc., have been reported to be effective in the treatment of dementia in Alzheimer’s disease (AD) as well as have shown inhibition in various virus infections. |
| 32828269 | The results of a screening effort involving a repurposing drug library of ion channel blockers yielded two compounds that inhibit the E protein: Gliclazide and Memantine. |